相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitreous and Serum Levels of Platelet-Derived Growth Factor and Their Correlation in Patients with Proliferative Diabetic Retinopathy
Anna Praidou et al.
CURRENT EYE RESEARCH (2009)
Intravitreal bevacizumab (Avastin®) in proliferative diabetic retinopathy
Angelo M. Minnella et al.
ACTA OPHTHALMOLOGICA (2008)
Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema
Wael Soliman et al.
ACTA OPHTHALMOLOGICA (2008)
Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)
Matheus Tonello et al.
ACTA OPHTHALMOLOGICA (2008)
Anti-vascular endothelial growth factor therapy for ocular neovascular disease
Christopher M. Andreoli et al.
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema
Quan Dong Nguyen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study)
Rodrigo Jorge et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
Christos Haritoglou et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles
Jignesh I. Patel et al.
EXPERIMENTAL EYE RESEARCH (2006)
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema
H Funatsu et al.
OPHTHALMOLOGY (2006)
Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
AP Adamis et al.
OPHTHALMOLOGY (2006)
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
ET Cunningham et al.
OPHTHALMOLOGY (2005)
Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema
H Funatsu et al.
OPHTHALMOLOGY (2005)
Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II
H Funatsu et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema
H Funatsu et al.
OPHTHALMOLOGY (2003)
Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy
N Ogata et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation
G Weibrich et al.
GROWTH FACTORS (2002)
The pathogenesis of diabetic retinopathy: old concepts and new questions
J Cai et al.
EYE (2002)
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders
H Funatsu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Platelet-derived growth factor-BB: A survival factor for the retinal microvasculature during periods of metabolic compromise
T Kodama et al.
CURRENT EYE RESEARCH (2001)
Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy
H Freyberger et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2000)
分享论文
